The US Anti Cancer Drug market is the largest market in the world which has registered a positive growth rate over the period. The rising growth rate can be attributed to an increasing number of drugs being approved by the United States Food and Drug Association along with the increasing number of cancer cases although many major drugs which lost their patent protection has hampered the growth of the market. The US Anti Cancer Drug Market has recorded a 5 year CAGR of 6.50% over the period. The sales of anti cancer drugs in the US grew from USD ~ billion in 2008 to USD ~ billion in 2013.
The Breast Cancer Drug Market is one of largest markets in terms of breast cancer drug sales with a global share of 59% and was valued at USD ~ billion in 2013. The breast cancer drug market though had a busy pipeline but has been mainly driven by sales of three major drugs namely Arimidex, Herceptin and Afinitor in recent years. Pancreatic cancer is one of the most researched segments as it cannot be diagnosed in a time leading to a fall in its survival rates. Avastin, Rituxan, Herceptin and Alimta were among the world’s top selling anti cancer drugs and each recorded sales above USD ~ million